References
- Calne RY, Rolles K, White DJ, et al. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet 1979;2:1033–1036.
- Hasenbein W, Albani J, Englert C, et al. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation. Pediatr Transplant 2006;10:938–942.
- Borel JF, Feurer C, Gubler HU, Stahelin H. Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions 1976;6:468–475.
- Hamawy MM. Molecular actions of calcineurin inhibitors. Drug News Perspect 2003;16:277–282.
- White DJ, Rolles K, Ottawa T, Turell O. Cyclosporin-A-induced long-term survival of fully incompatible skin and heart grafts in rats. Transplant Proc 1980;12:261–265.
- Rezzani R. Exploring cyclosporine A-side effects and the protective role-played by antioxidants: the morphological and immunohistochemical studies. Histol Histopathol 2006;21:301–316.
- Calne R. Cyclosporine as a milestone in immunosuppression. Transplant Proc 2004;36:13S–15S.
- Chen B, Zang CS, Zhang JZ, et al. The changes of aquaporin 2 in the graft of acute rejection rat renal transplantation model. Transplant Proc 2010;42:1884–1887.
- Fiedel S, Bayer J, Schaub M, et al. The influence of antigen-dependent and antigen-independent factors on the development of graft vasculopathy in a fully allogeneic cardiac allograft model in the rat. Transplant Proc 2009;41:2625–2627.
- Gao LH, Zheng SS, Zhu YF, et al. A rat model of chronic allograft liver rejection. Transplant Proc 2005;37:2327–2332.
- Rijkelijkhuizen JK, Tons A, Terpstra OT, Bouwman E. Transplantation of long-term cultured porcine islets in the rat: prolonged graft survival and recipient growth on reduced immunosuppression. Cell Transplant 2010;19:387–398.
- Sun Z, Zhang X, Locke JE, et al. Recruitment of host progenitor cells in rat liver transplants. Hepatology 2009;49:587–597.
- Unadkat JV, Schneeberger S, Goldbach C, et al. Investigation of antibody-mediated rejection in composite tissue allotransplantation in a rat limb transplant model. Transplant Proc 2009;41:542–545.
- Wee YM, Choi MY, Kang CH, et al. The synergistic effect of Tautomycetin on Cyclosporine A-mediated immunosuppression in a rodent islet allograft model. Mol Med 2010;16:298–306.
- Yang YL, Li JP, Dou KF, Li KZ. Influence of liver nonparenchymal cell infusion combined with cyclosporin A on rejection of rat small bowel transplantation. World J Gastroenterol 2003;9:2859–2862.
- Zijlstra GS, Wolting J, Prop J, et al. Efficacy of a new pulmonary cyclosporine a powder formulation for prevention of transplant rejection in rats. J Heart Lung Transplant 2009;28:486–492.
- Navarro C, Seguy L, Vila M, Birckel P. Bioequivalence study between two formulations of ciclosporin A (Cyclavance® oral solution and Atopica® soft capsules) following a single oral administration to dogs. BMC Vet Res 2016;12:54.
- Pruessner JC, Kirschbaum C, Meinlschmid G, Hellhammer DH. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 2003;28:916–931.
- Damiano S, Ciarcia R, Montagnaro S, et al. Prevention of nephrotoxicity induced by cyclosporine-A: role of antioxidants. J Cell Biochem 2015;116:364–369.
- Capasso G, Di Gennaro CI, Della Ragione F, et al. In vivo effect of the natural antioxidant hydroxytyrosol on cyclosporine nephrotoxicity in rats. Nephrol Dial Transplant 2008;23:1186–1195.
- Nader MA, Attia GM. Beneficial effects of nilotinib, tyrosine kinase inhibitor on cyclosporine-A induced renal damage in rats. Int Immunopharmacol 2016;33:1–7.
- Patel L, Thaker A. The effects of A2B receptor modulators on vascular endothelial growth factor and nitric oxide axis in chronic cyclosporine nephropathy. J Pharmacol Pharmacother 2015;6:147–153.
- Miller LW. Cyclosporine-associated neurotoxicity. The need for a better guide for immunosuppressive therapy. Circulation 1996;94:1209–1211.
- Pan H, Gazarian A, Buff S, et al. Oral cyclosporine A in neonatal swines for transplantation studies. Immunopharmacol Immunotoxicol 2015;37:19–25.
- Ateyya H. Amelioration of cyclosporine induced nephrotoxicity by dipeptidyl peptidase inhibitor vildagliptin. Int Immunopharmacol 2015;28:571–577.
- Maerckx C, Tondreau T, Berardis S, et al. Human liver stem/progenitor cells decrease serum bilirubin in hyperbilirubinemic Gunn rat. World J Gastroenterol 2014;20:10553–10563.